Physician profile
Christa S Cooper
NPI 1831440254
$35,785.58
in general payments reported to CMS, 2019-2025
8 companies · $31K in 2025
The $31K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $286 · 2023: $3,898 · 2024: $603 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Consulting Fee: $10K · Travel and Lodging: $6,508 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,500 · Food and Beverage: $1,767 · Education: $99.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,459.50 |
| Consulting Fee | $10,165.00 |
| Travel and Lodging | $6,508.36 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,500.00 |
| Food and Beverage | $1,767.07 |
| Education | $99.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $12,966.84 | 2023-2025 | Ingrezza, Ongentys |
| Teva Pharmaceuticals USA, INC. | $11,844.00 | 2023-2025 | Austedo Xr |
| Abbott Laboratories | $9,299.78 | 2022-2025 | Infinity, Proclaim |
| Acadia Pharmaceuticals INC | $997.85 | 2023 | Nuplazid |
| Mdd US Operations, LLC | $500.00 | 2025 | |
| Boston Scientific Corporation | $110.90 | 2022 | |
| Medtronic, INC. | $48.91 | 2024-2025 | Sensight, Percept PC Brainsense |
| Cala Health, INC. | $17.30 | 2025 | Cala Kiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christa Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.